Atrazine-induced carcinogenesis in colorectal cancer: Core gene identification, immune cell infiltration, and

Laiming Mo1, Siyang Yu1, Huijun Zhu2

  • 1Department of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-Sen University, Guangming District, Shenzhen, Guangdong 518107, China.

Abstract

Insights

The environmental pollutant Atrazine promotes colorectal cancer (CRC) by affecting multiple molecular targets and pathways. ABCC1 is identified as a key gene linking Atrazine exposure to increased CRC cell proliferation and migration.

Area of Science:

  • Environmental Toxicology
  • Cancer Biology
  • Molecular Mechanisms

Background:

  • Atrazine is an environmental pollutant with suspected carcinogenic properties.
  • Colorectal cancer (CRC) is a significant global health concern.
  • Understanding the molecular link between environmental factors and cancer is crucial for prevention and treatment.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Atrazine promotes colorectal cancer (CRC) tumorigenesis and progression.
  • To identify key genes and pathways involved in Atrazine-induced CRC.

Main Methods:

  • In silico toxicological assessments (ADMETlab, ProTox), target prediction (SuperPred, TargetNet, SwissTargetPrediction, STITCH), and pathway analysis (GO, KEGG, Metascape).
  • Machine learning models using transcriptomic data (GEO) to identify core genes, validated by gene expression and protein localization data (HPA).
  • Molecular docking (CB-Dock2), nomogram construction, GSEA, immune infiltration analysis (CIBERSORT, TISCH2), SHAP analysis, and in vitro functional assays (CCK-8, wound healing, qPCR).

Main Results:

  • Atrazine demonstrated significant carcinogenicity and multi-system toxicity.
  • Six core genes were identified, with ABCC1, MMP7, GSTP1, and MIF upregulated, and SGK1 and PTGS1 downregulated in CRC.
  • ABCC1 showed the strongest binding affinity with Atrazine and was identified as a key contributor to CRC progression, enhancing cell proliferation and migration.
  • In vitro assays confirmed Atrazine's role in promoting CRC cell growth and motility, with significant ABCC1 upregulation.

Conclusions:

  • Atrazine promotes CRC progression via multi-target and multi-pathway mechanisms.
  • ABCC1 is a central gene mediating the effects of Atrazine on CRC cell proliferation and migration.
  • These findings highlight the oncogenic role of Atrazine and identify ABCC1 as a potential therapeutic target.